Literature DB >> 15686506

Assessment of neutrophil activation in whole blood by flow cytometry.

A Alvarez-Larrán1, T Toll, S Rives, J Estella.   

Abstract

Flow cytometry methods currently used for measuring neutrophil activation involve sample manipulation, which may result in cellular depletion and artifactual activation. To design a new methodology for measurement of neutrophil activation with minimal sample manipulation. Oxidative burst and CD 11b neutrophil expression were simultaneously assessed by a new no-lyse no-wash technique and a standard lyse-method in 10 pediatric patients with recurrent infections and two patients with chronic granulomatous disease (CGD). The new technique was based on nucleic acid staining to discriminate erythrocytes and debris without requiring physical separation. Both methods served equally to confirm or eliminate the diagnosis of CGD and leukocyte adhesion deficiency type 1. The values of baseline CD11b and oxidative burst obtained using the lysis method were significantly higher than those obtained by the no-lyse no-wash method. After activation, the lysis method resulted in higher neutrophil depletion (41%vs. 19%, P = 0.03). When compared with standard methods, neutrophil activation assessment by a no-lyse no-wash method resulted in lower neutrophil depletion and differences in oxidative burst and CD11b neutrophil values.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15686506     DOI: 10.1111/j.1365-2257.2004.00661.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  8 in total

1.  Expression of CD11c and EMR2 on neutrophils: potential diagnostic biomarkers for sepsis and systemic inflammation.

Authors:  S M Lewis; D F Treacher; J Edgeworth; G Mahalingam; C S Brown; T A Mare; M Stacey; R Beale; K A Brown
Journal:  Clin Exp Immunol       Date:  2015-09-22       Impact factor: 4.330

2.  Neutrophil isolation from nonhuman species.

Authors:  Daniel W Siemsen; Natalia Malachowa; Igor A Schepetkin; Adeline R Whitney; Liliya N Kirpotina; Benfang Lei; Frank R Deleo; Mark T Quinn
Journal:  Methods Mol Biol       Date:  2014

3.  Acute-Phase Deaths from Murine Polymicrobial Sepsis Are Characterized by Innate Immune Suppression Rather Than Exhaustion.

Authors:  Evan L Chiswick; Juan R Mella; John Bernardo; Daniel G Remick
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

4.  Comparison of sample fixation and the use of LDS-751 or anti-CD45 for leukocyte identification in mouse whole blood for flow cytometry.

Authors:  Melissa L Maes; Lisa B Davidson; Paul F McDonagh; Leslie S Ritter
Journal:  J Immunol Methods       Date:  2006-12-08       Impact factor: 2.303

5.  A Flow Cytometry-Based Assay for High-Throughput Detection and Quantification of Neutrophil Extracellular Traps in Mixed Cell Populations.

Authors:  Olga Zharkova; Sen Hee Tay; Hui Yin Lee; Tripathi Shubhita; Wei Yee Ong; Aisha Lateef; Paul Anthony MacAry; Lina Hsiu Kim Lim; John Edward Connolly; Anna-Marie Fairhurst
Journal:  Cytometry A       Date:  2018-12-14       Impact factor: 4.355

Review 6.  Neutrophil heterogeneity and its role in infectious complications after severe trauma.

Authors:  Lillian Hesselink; Roy Spijkerman; Karlijn J P van Wessem; Leo Koenderman; Luke P H Leenen; Markus Huber-Lang; Falco Hietbrink
Journal:  World J Emerg Surg       Date:  2019-05-29       Impact factor: 5.469

7.  NET Release of Long-Term Surviving Neutrophils.

Authors:  Jan Philipp Kolman; Laia Pagerols Raluy; Ingo Müller; Viacheslav O Nikolaev; Magdalena Trochimiuk; Birgit Appl; Hannah Wadehn; Charlotte Maria Dücker; Fabian David Stoll; Michael Boettcher; Konrad Reinshagen; Julian Trah
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

8.  Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome.

Authors:  Charlotte Summers; Nanak R Singh; Jessica F White; Iain M Mackenzie; Andrew Johnston; Chandra Solanki; K K Balan; A Michael Peters; Edwin R Chilvers
Journal:  Thorax       Date:  2014-04-04       Impact factor: 9.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.